ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
gavint66
|
805 |
328K |
5 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
805
|
328K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
gavint66
|
199 |
71K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
199
|
71K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
gavint66
|
5.4K |
2.7M |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
5.4K
|
2.7M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
gavint66
|
199 |
71K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
199
|
71K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
gavint66
|
199 |
71K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
199
|
71K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: DFU Clinical Trial Enrolment Complete
|
|
gavint66
|
33 |
8.8K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
33
|
8.8K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
gavint66
|
1.0K |
423K |
9 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
9
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Presentation on ASX Gems Conference on 21st June
|
|
gavint66
|
199 |
71K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
199
|
71K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
gavint66
|
225 |
81K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
225
|
81K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
ME1 |
Re:
Ann: Consolidation/Split - ME1
|
|
gavint66
|
158 |
48K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
158
|
48K
|
2
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
15/06/24 |
15/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
gavint66
|
1.0K |
423K |
5 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
gavint66
|
1.0K |
423K |
1 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
gavint66
|
1.0K |
423K |
5 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
1.0K
|
423K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Further GvHD Clinical Data Published in Nature Medicine
|
|
gavint66
|
12 |
3.4K |
0 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
12
|
3.4K
|
0
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
1 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
609
|
105K
|
1
|
|
ASX - By Stock
|
CKA |
Re:
Ann: Infrastructure Joint Venture Advances to the Next Stage
|
|
gavint66
|
378 |
70K |
6 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
378
|
70K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Investor Presentation
|
|
gavint66
|
609 |
105K |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
609
|
105K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Australian newspaper article
|
|
gavint66
|
225 |
81K |
6 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
225
|
81K
|
6
|
|